Jonathan Poole resigned as CFO of Genocea Biosciences Inc., effective March 23.
Poole resigned to pursue another professional opportunity. He will assist in the transition of the CFO role until his departure.
The company is conducting a search to replace Poole, and pending the conclusion of that search, President and CEO William Clark will assume the duties of principal financial officer and principal accounting officer.
Cambridge, Mass.-based Genocea is a biopharmaceutical company engaged in developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
